Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in PCD pharma franchise in Hyderabad

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma manufacturing company in Pune

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in respiratory care pharma franchise in India

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in PCD pharma suppliers in Delhi

Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma franchise in Mumbai
Ambroxol 7.5mg + Levosalbutamol 0.25mg + Guaifenesin 12.5mg Syrup in pharma export companies in India

Home/Products /levosalbutamol-0-point-25mg-ambroxol-7-point-5mg-guaifenesin-12-point-5mg-drop

About the Product

Description


Cufsniff LS Drop combines Ambroxol (7.5mg)Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.

Cufsniff LS Drop is generally well-tolerated. However, some individuals may experience mild side effects such as nausea, dizziness, headache, or dry mouth. In rare cases, allergic reactions such as rash, itching, or swelling may occur. If any severe side effects or allergic reactions appear, stop the medication immediately and consult a healthcare provider.

Cufsniff LS Drop is indicated for the relief of cough, mucus congestion, and difficulty in breathing due to conditions like bronchitis, asthma, and other respiratory tract infections. It helps in clearing mucus from the airways, easing coughing, and improving overall respiratory health.

This product is intended for short-term use. If symptoms persist or worsen, consult a healthcare professional. Not suitable for children under 2 years unless directed by a physician. Individuals with a history of heart disease or high blood pressure should consult a healthcare provider before use.

Store in a cool, dry place, away from direct sunlight. Keep the bottle tightly closed and out of reach of children. Ensure proper storage to maintain the efficacy of the product.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levosalbutamol 0.25mg + Ambroxol 7.5mg + Guaifenesin 12.5mg Drops in the PCD pharma franchise market?

This combination respiratory drop is used for cough with mucus, bronchial congestion, wheezing, and respiratory infections, especially in pediatric patients. It combines bronchodilator, mucolytic, and expectorant actions, making it a strong pediatric respiratory segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this product in their range?

Medical distributors and wholesalers can benefit from consistent demand in pediatric clinics, general physicians, and respiratory care prescriptions. It is commonly used for wet cough with chest congestion in children, ensuring strong seasonal and recurring pharmacy sales.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for pediatric and respiratory formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this pediatric respiratory product?

Wholesalers and medical agencies benefit from strong pediatric prescriptions, seasonal demand, hospital usage, and repeat purchases in respiratory infection management when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this drops formulation?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this pediatric respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.